Consistent with these research studies, our present results uncovered that SAHA treatment significantly altered the acetylation level of the MYC pathway in 5–8 F cells, which might be one of the principles of SAHA to play roles in NPC cells. The gene discussed is MYC; the disease is nasopharyngeal carcinoma.